Market Survey on Pessary Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Pessary Market including Gellhorn, Ring, and Donut Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
A newly released Pessary Market analysis report by Future Market Insights shows that global sales of the Pessary Market in 2021 were held at US$ 289.8 Million.With a CAGR of 10.2%, themarketisprojected to reach a valuation of US$ 831.3 Million by 2032. Ring Pessary is expected to be the highest revenue-generating category, projected to register a CAGR of 11.2%from 2022 to 2032.
Attributes
Details
Global Pessary Market Size (2022)
US$ 316 Million
Global Pessary Market Size (2032)
US$ 831.3 Million
Global Pessary Market CAGR (2022 to 2032)
10.2%
USA Pessary Market CAGR (2022 to 2032)
11.1%
Key Companies Covered
MedGyn Products, Inc.
Cooper Surgical Inc.
Personal Medical Corp.
Panpac Medical Corp
Smiths Medical
Thomas Medical
Artisan Medical
Bioteque America, Inc.
Integra LifeSciences Corporation
Dr. Arabin GmbH & Co.
Medgyn Products, Inc.
Wallach Surgical Devices
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Revenue of Pessary Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032
As per the Pessary Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pessary Market increased at around 8.5% CAGR.
The aging population, together with pessaries' high success rate, has been driving the growth of the pessary market. Furthermore, lifestyle-related diseases are becoming more prevalent. The growing prevalence of diseases like pelvic organ prolapse and urinary incontinence will drive the pessary market. Furthermore, growing global awareness of the importance of pessaries during pelvic organ prolapse complications will serve as a growth driver.
For women with POP who want nonsurgical management, a future pregnancy, early-stage prolapse, or are too frail for surgery, pessaries are typically recommended as a first-line treatment option. Patients whose stress incontinence is aggravated by strenuous physical activity may benefit from pessaries. Pessaries provide an opportunity to simulate postsurgical conditions and help patients' expectations regarding symptom reduction in women who present with pelvic pain, back pain, and pressure thought to be caused by POP operations.
Several studies on the success rate of pessary fitting have been conducted, with results ranging from 41% to 74%. Success rates as high as 62 percent have been observed in patients with stage III and IV prolapse, suggesting that pessaries are an excellent option for all populations with severe POP. In the United States, approximately 200,000 POP operations are performed each year. Although not life-threatening, POP could have a major impact on women's standard of living.
What Factors are Propelling the Pessary Demand?
The Fourth International Consultation on Incontinence recommends pessaries, pelvic floor muscle training, and lifestyle counseling as conservative management options for women with Pelvic Organ Prolapse. Vaginal vault prolapse, or some other type of pelvic organ prolapse, affects approximately half of the women aged 50 to 80 years. Childbirth, age, fatness, gastrointestinal issues, or a hysterectomy can all cause uterine prolapse and increase the demand for pessaries.
Because they provide simple, affordable, and safe solutions, vaginal pessaries are a popular treatment option for organ prolapse and incontinence. These factors contribute to the higher patient satisfaction rate in comparison to an alternate solution. As a result, pessaries are now preferred as first-line treatment for POP or stress urinary incontinence.
Among the key factors expected to drive the market during the forecast period are frequent product introductions, a strong emphasis on Research and Development by market players and universities, geographical expansion by key players, and a number of government initiatives. The United Kingdom Clinical Guideline for Proper Procedure in the Use of Vaginal Pessaries for POP is a document prepared by medical professionals and supporters of prolapse pessaries. The goal of the Guideline is to provide multidisciplinary healthcare professionals with guidance and information on best practices in pessary use for prolapse.
Find your sweet spots for generating winning opportunities in this market.
How the emergence of Modern Pessaries pulled the growth trigger in Pessary Market?
Pessaries are now made of non-reactive silicone and come in a variety of designs and sizes to accommodate everyone. Silicon has low surface tension and remarkable chemical stability, allowing for biocompatibility and bio-durability in many long-term implant applications, making it suitable for medical applications.
Pessaries can be used as a stopgap measure for women who want to stop having children or are waiting for surgery. It can also be used as a long-term solution for women who do not qualify for surgery.
In June 2021, using artificial intelligence-driven machine learning and 3D design, Femtherapeutics Inc. developed a device to relieve urinary incontinence and discomfort in women suffering from pelvic organ prolapse. Unlike traditional pessaries, which can cause irritation and penetrate soft tissues, resulting in bleeding, the custom-made pessary is intended to support displaced vaginal tissues caused by the condition.
Region-wise Analysis
Which Region is projected to Offer the Largest Opportunity for Pessary Market?
Asia Pacific is the most lucrative region with double-digit projected growth. The fastest rate of expansion in the regional finance industry is predicted to result from younger, expanding populations and a growing focus on wellness.
As the elderly are more prone to incontinence and prolapsed organ disorders (POP), there is a sizable market in this region, with Japan, China, and India being the primary suppliers. Medical tourism is also a key driver behind the market's growth here.
In developing countries, the extent and effects of morbidity associated with pelvic organ prolapse are rarely acknowledged due to patient embarrassment. However, research funded by the United Nations Population Fund (UNFPA) in Nepal has begun to identify the suffering of women from this disorder. UNFPA is assisting in the identification of women with pelvic organ prolapse through reproductive health camps and the hiring of gynecologists to treat these women at district hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Analysis
USA Pessary Market Analysis
The USA is expected to have the largest market of US$ 323.2 Million by the end of 2032 with North America being the dominant player and accounting for over 35% of total sales. With the elderly population in the United States increasing, there is renewed interest in pessaries as a less invasive alternative to surgical repair for pelvic organ prolapse (POP).
They are an excellent choice for women who have not finished having children, do not want surgery, or are ineligible for surgery. Patients suffering from POP and stress urinary incontinence may benefit from long-term pessary use. Although serious side effects are uncommon, many patients find it difficult to insert and remove most pessary types. The design of pessaries should continue to improve, making their use more appealing.
Women in the USA have an 11% lifetime risk of having prolapse or incontinence surgery by the age of 80, with a 30% chance of reoperation after four years. The number of women over the age of 65 in the USA is expected to more than double to reach more than 40 million by 2030, according to the USA Census Bureau.
As the United States population ages, there is renewed interest in the use of pessaries. According to a survey conducted by the American Urogynaecology Society, 77% of those polled used pessaries as their first-line POP therapy. The pessary is still a viable treatment option for prolapse and incontinence.
United Kingdom Pessary Market Analysis
The market in the United Kingdom is expected to gross US$ 42 Million by 2032. The market in the country is expected to witness a CAGR of 12.1% during the forecast period, registering an absolute dollar opportunity of US$ 28.2 Million.
Japan Pessary Market Analysis
In Japan, the market is expected to reach a valuation of US$ 30 Million by 2032. With an absolute dollar opportunity of US$ 20.7 Million during the forecast period, the market is expected to register a CAGR of 12.7%.
South Korea Pessary Market Analysis
The market in South Korea is expected to gross an absolute dollar opportunity of US$ 9.9 Million by 2032. Growing at a CAGR of 10.8% from 2022 to 2032, the market is likely to reach a valuation of US$ 15.5 Million.
Category-wise Insights
Which Pessary Segment is projected to Witness Most Opportunity?
The Ring Pessary segment is forecasted to grow at the highest CAGR of over 11% from 2022 to 2032. Because of their ease of insertion and removal, ring pessaries are typically the first-line pessary for clinicians. They can be used at any stage of POP, but the first and second stages are the most common. The catheter is unfolded once above the pubic symphysis after being inserted into the vagina. The pessary is gently pulled and folded in half to be removed. To help with insertion and removal, a string can be attached to the ring. Patients can easily learn how to do this on their own.
A new disposable, non-invasive vaginal ring pessary is used at home to treat a variety of pelvic floor disorders. The ConTIPI Medical ProVate, for example, is made of a flexible skeleton covered by a soft elastomer and is designed to expand in the vagina, separating the lateral vaginal walls and mechanically preventing cervical and vault descent as well as blocking further descent of the anterior and posterior walls within the rings hollow.
Which Product Type of Pessary is expected to Score the Highest Growth in the Coming Years?
The Hospitals segment is forecasted to grow at the highest CAGR of over 11.4% from 2022 to 2032. With 45% of the total revenue, the hospital segment dominated the vaginal pessary market. This could be attributed to the rising market demand for pessaries among post-operative and hospitalized indwellings. Among factors contributing to the segment's growth is the heightened interest in the notion of organ prolapse, urinary incontinence, and the inclusion of pessaries in private insurance policies. Surgeons are increasingly favoring minimally invasive procedures that will limit post-operation complications and increase recovery times.
Competitive Analysis
Among the leading players in the global Pessary market are Integra Lifesciences, Panpac Medical Corporation, Personal Medical Corporation, Dr. Arabin GmbH & Co., and Wallach Surgical Devices. To gain a competitive advantage in the industry, these market players are investing in product launches, partnerships, mergers and acquisitions, and expansions.
Some of the recent developments in the pessary market are mentioned below:
In February 2022, CooperCompanies agreed to purchase Cook Medical's Reproductive Health division, which manufactures noninvasive fertility, obstetrics, and gynecology devices. Cooper will pay US$ 875 million in total, with US$ 675 million paid at closing and the remaining US$ 200 million paid in four US$ 50 million annual installments.
In February 2022, Theramex, a global pharmaceutical company specializing in women's health expanded its initial collaboration with Endoceutics to commercialize Intrarosa in Australia. Intrarosa is the first and only DHEA treatment that has been approved for postmenopausal women suffering from moderate to severe vulvovaginal atrophy.
In August 2021, Liv Labs developed a reusable female comfort pessary that does not require a doctor's prescription. Patients suffering from incontinence are currently fitted for pessaries, which must be worn for six months before being removed.
The Liv Labs pessary is soft, smooth, and squishy, making insertion and removal easier. It is made of medical-grade silicone. Women can use it whenever they want, whether it is all day or just for a quick trip to the gym.
Similarly, the team at Future Market Insights, which is available in the full report, has tracked recent developments related to companies in the Pessary market
Market Segments Covered in Pessary Market Analysis
By Type:
Gellhorn
Ring
Donut
Other Types
By End-Use:
Hospitals
Ambulatory Surgical Centres
Clinics
By Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Frequently Asked Questions
How much is the current worth of the Pessary Market?
The global market is worth more than US$ 289.8 Million at present.
What is the sales forecast for Pessary Market?
The value of the Pessary Market is projected to increase at a CAGR of around 10.2% from 2022 to 2032.
What was the last 5 year’s market CAGR?
The value of the Pessary Market increased at a CAGR of around 8.5% from 2017 to 2021.
What is a key trend shaping the growth of the Pessary Market?
The increasing incidence of pelvic organ prolapse (POP), and urinary incontinence amongst the majority of women, stand as the key trend in the Pessary market.
At what percentage is sales of Pessary Market going to register growth in USA?
The pessary Market in the USA is projected to expand at a CAGR of around 11.1% from 2022 to 2032.
Table of Content
1. Executive Summary | Pessary Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Investment Feasibility Matrix
3.4. PESTLE and Porter’s Analysis
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032
5.3.1. Gellhorn
5.3.2. Ring
5.3.3. Donut
5.3.4. Other Types
5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centres
6.3.3. Clinics
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia
7.3.6. Oceania
7.3.7. Middle East and Africa(MEA)
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Argentina
9.2.1.4. Rest of Latin America
9.2.2. By Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. United Kingdom
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By End User
10.4. Key Takeaways
11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Malaysia
12.2.1.4. Indonesia
12.2.1.5. Rest of South Asia
12.2.2. By Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By End User
12.4. Key Takeaways
13. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Type
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By End User
13.4. Key Takeaways
14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Rest of Middle East and Africa(MEA)
14.2.2. By Type
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Type
15.1.2.2. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Type
15.2.2.2. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Type
15.3.2.2. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Type
15.4.2.2. By End User
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Type
15.5.2.2. By End User
15.6. Germany
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Type
15.6.2.2. By End User
15.7. Italy
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Type
15.7.2.2. By End User
15.8. France
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Type
15.8.2.2. By End User
15.9. United Kingdom
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Type
15.9.2.2. By End User
15.10. Spain
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Type
15.10.2.2. By End User
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Type
15.11.2.2. By End User
15.12. BENELUX
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Type
15.12.2.2. By End User
15.13. China
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Type
15.13.2.2. By End User
15.14. Japan
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Type
15.14.2.2. By End User
15.15. South Korea
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Type
15.15.2.2. By End User
15.16. India
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Type
15.16.2.2. By End User
15.17. Thailand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Type
15.17.2.2. By End User
15.18. Malaysia
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Type
15.18.2.2. By End User
15.19. Indonesia
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Type
15.19.2.2. By End User
15.20. Australia
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Type
15.20.2.2. By End User
15.21. New Zealand
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Type
15.21.2.2. By End User
15.22. GCC Countries
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2021
15.22.2.1. By Type
15.22.2.2. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. MedGyn Products, Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Cooper Surgical Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Personal Medical Corp.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Panpac Medical Corp
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Smiths Medical
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Thomas Medical
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Artisan Medical
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Bioteque America, Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Integra LifeSciences Corporation
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Dr. Arabin GmbH & Co.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Medgyn Products, Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Wallach Surgical Devices
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 3: Global Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 5: North America Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 6: North America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 8: Latin America Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 11: Europe Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 12: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 13: East Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 14: East Asia Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 15: East Asia Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 16: South Asia Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 17: South Asia Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 18: South Asia Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 20: Oceania Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 21: Oceania Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 22: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 23: MEA Market Value (US$ Million) Forecast by Type, 2017 to 2032
Table 24: MEA Market Value (US$ Million) Forecast by End User, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Type, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by End User, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 7: Global Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 13: Global Market Attractiveness by Type, 2022 to 2032
Figure 14: Global Market Attractiveness by End User, 2022 to 2032
Figure 15: Global Market Attractiveness by Region, 2022 to 2032
Figure 16: North America Market Value (US$ Million) by Type, 2022 to 2032
Figure 17: North America Market Value (US$ Million) by End User, 2022 to 2032
Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 22: North America Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 28: North America Market Attractiveness by Type, 2022 to 2032
Figure 29: North America Market Attractiveness by End User, 2022 to 2032
Figure 30: North America Market Attractiveness by Country, 2022 to 2032
Figure 31: Latin America Market Value (US$ Million) by Type, 2022 to 2032
Figure 32: Latin America Market Value (US$ Million) by End User, 2022 to 2032
Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 37: Latin America Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 43: Latin America Market Attractiveness by Type, 2022 to 2032
Figure 44: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 46: Europe Market Value (US$ Million) by Type, 2022 to 2032
Figure 47: Europe Market Value (US$ Million) by End User, 2022 to 2032
Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 52: Europe Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 55: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 58: Europe Market Attractiveness by Type, 2022 to 2032
Figure 59: Europe Market Attractiveness by End User, 2022 to 2032
Figure 60: Europe Market Attractiveness by Country, 2022 to 2032
Figure 61: East Asia Market Value (US$ Million) by Type, 2022 to 2032
Figure 62: East Asia Market Value (US$ Million) by End User, 2022 to 2032
Figure 63: East Asia Market Value (US$ Million) by Country, 2022 to 2032
Figure 64: East Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 65: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 66: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 67: East Asia Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 68: East Asia Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 69: East Asia Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 70: East Asia Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 71: East Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 72: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 73: East Asia Market Attractiveness by Type, 2022 to 2032
Figure 74: East Asia Market Attractiveness by End User, 2022 to 2032
Figure 75: East Asia Market Attractiveness by Country, 2022 to 2032
Figure 76: South Asia Market Value (US$ Million) by Type, 2022 to 2032
Figure 77: South Asia Market Value (US$ Million) by End User, 2022 to 2032
Figure 78: South Asia Market Value (US$ Million) by Country, 2022 to 2032
Figure 79: South Asia Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 80: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 81: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 82: South Asia Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 83: South Asia Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 84: South Asia Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 85: South Asia Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 86: South Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 87: South Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 88: South Asia Market Attractiveness by Type, 2022 to 2032
Figure 89: South Asia Market Attractiveness by End User, 2022 to 2032
Figure 90: South Asia Market Attractiveness by Country, 2022 to 2032
Figure 91: Oceania Market Value (US$ Million) by Type, 2022 to 2032
Figure 92: Oceania Market Value (US$ Million) by End User, 2022 to 2032
Figure 93: Oceania Market Value (US$ Million) by Country, 2022 to 2032
Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 97: Oceania Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 98: Oceania Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 100: Oceania Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 101: Oceania Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 103: Oceania Market Attractiveness by Type, 2022 to 2032
Figure 104: Oceania Market Attractiveness by End User, 2022 to 2032
Figure 105: Oceania Market Attractiveness by Country, 2022 to 2032
Figure 106: MEA Market Value (US$ Million) by Type, 2022 to 2032
Figure 107: MEA Market Value (US$ Million) by End User, 2022 to 2032
Figure 108: MEA Market Value (US$ Million) by Country, 2022 to 2032
Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 112: MEA Market Value (US$ Million) Analysis by Type, 2017 to 2032
Figure 113: MEA Market Value Share (%) and BPS Analysis by Type, 2022 to 2032
Figure 114: MEA Market Y-o-Y Growth (%) Projections by Type, 2022 to 2032
Figure 115: MEA Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 116: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 117: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 118: MEA Market Attractiveness by Type, 2022 to 2032
Figure 119: MEA Market Attractiveness by End User, 2022 to 2032
Figure 120: MEA Market Attractiveness by Country, 2022 to 2032
